Get started
Work

Abstract PS1-08-08: monarchE: subgroup analysis of adjuvant abemaciclib + endocrine therapy for HR+, HER2-, high-risk early breast cancer by nodal status

Year: 2026
Type: conference-abstract
DOI: 10.1158/1557-3265.sabcs25-ps1-08-08
Authors: J. Cortes, S. R. D. Johnston, M. Martín, S. M. Tolaney, M. Goetz, H. Rugo, J. Sohn, O. Ozyilkan, M. Henriques Abreu, M. Zaiss, K. Maia Vianna, H. Melgaard Nielsen, A. Chan, H. Kalofonos, S. Morales, B. San Antonio, M. Munoz, B. R Grimes, S. Amdur, P. Neven
Institutions: IDCQ Hospitales y Sanidad, S.L.U., Royal Marsden Hospital, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Cáncer, GEICAM – Spanish Breast Cancer Group, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Mayo Clinic, City Of Hope National Medical Center, City of Hope, Yonsei Cancer Hospital, Başkent University, IPO Porto, Aarhus University Hospital, Curtin University, University of Patras, Hospital Universitari Arnau de Vilanova, Eli Lilly (United States), Universitair Ziekenhuis Leuven
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7129546474
Cites:
Cited by:
Related to: